NT 10-K

AXIM BIOTECHNOLOGIES, INC. FORM 12B-25

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: March 31, 2022
Period of Report: December 31, 2021
Accession Number: 0001096906-22-000699

View Document ↗ View on SEC.gov ↗